These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 20680390)
1. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Getty AL; Pearce DA Cell Mol Life Sci; 2011 Feb; 68(3):453-74. PubMed ID: 20680390 [TBL] [Abstract][Full Text] [Related]
3. Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses. Sima N; Li R; Huang W; Xu M; Beers J; Zou J; Titus S; Ottinger EA; Marugan JJ; Xie X; Zheng W Orphanet J Rare Dis; 2018 Apr; 13(1):54. PubMed ID: 29631617 [TBL] [Abstract][Full Text] [Related]
4. Developmental changes in the expression of neuronal ceroid lipofuscinoses-linked proteins. Suopanki J; Partanen S; Ezaki J; Baumann M; Kominami E; Tyynelä J Mol Genet Metab; 2000; 71(1-2):190-4. PubMed ID: 11001810 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. Teixeira C; Guimarães A; Bessa C; Ferreira MJ; Lopes L; Pinto E; Pinto R; Boustany RM; Sá Miranda MC; Ribeiro MG J Neurol; 2003 Jun; 250(6):661-7. PubMed ID: 12796825 [TBL] [Abstract][Full Text] [Related]
6. Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis. Geraets RD; Koh Sy; Hastings ML; Kielian T; Pearce DA; Weimer JM Orphanet J Rare Dis; 2016 Apr; 11():40. PubMed ID: 27083890 [TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5. Mole SE; Mitchison HM; Munroe PB Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428 [TBL] [Abstract][Full Text] [Related]
8. Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients. Sheth J; Mistri M; Bhavsar R; Pancholi D; Kamate M; Gupta N; Kabra M; Mehta S; Nampoothiri S; Thakker A; Jain V; Shah R; Sheth F BMC Neurol; 2018 Dec; 18(1):203. PubMed ID: 30541466 [TBL] [Abstract][Full Text] [Related]
9. Partial genetic suppression of a loss-of-function mutant of the neuronal ceroid lipofuscinosis-associated protease TPP1 in Dictyostelium discoideum. Phillips JE; Gomer RH Dis Model Mech; 2015 Feb; 8(2):147-56. PubMed ID: 25540127 [TBL] [Abstract][Full Text] [Related]
10. A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis. Sanders DN; Kanazono S; Wininger FA; Whiting RE; Flournoy CA; Coates JR; Castaner LJ; O'Brien DP; Katz ML Genes Brain Behav; 2011 Oct; 10(7):798-804. PubMed ID: 21745338 [TBL] [Abstract][Full Text] [Related]
11. The neuronal ceroid-lipofuscinoses. Bennett MJ; Rakheja D Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013 [TBL] [Abstract][Full Text] [Related]
12. The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis. Miller JN; Chan CH; Pearce DA Hum Mol Genet; 2013 Jul; 22(13):2723-34. PubMed ID: 23539563 [TBL] [Abstract][Full Text] [Related]
13. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Weimer JM; Kriscenski-Perry E; Elshatory Y; Pearce DA Neuromolecular Med; 2002; 1(2):111-24. PubMed ID: 12025857 [TBL] [Abstract][Full Text] [Related]
14. The molecular genetic basis of the neuronal ceroid lipofuscinoses. Gardiner RM Neurol Sci; 2000; 21(3 Suppl):S15-9. PubMed ID: 11073223 [TBL] [Abstract][Full Text] [Related]
15. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients. Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312 [TBL] [Abstract][Full Text] [Related]
16. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis. Yu F; Liu XM; Chen YH; Zhang SQ; Wang K Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578 [No Abstract] [Full Text] [Related]
18. Glial fibrillary acidic protein is elevated in the lysosomal storage disease classical late-infantile neuronal ceroid lipofuscinosis, but is not a component of the storage material. Xu S; Sleat DE; Jadot M; Lobel P Biochem J; 2010 May; 428(3):355-62. PubMed ID: 20370715 [TBL] [Abstract][Full Text] [Related]
19. Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis. Vuillemenot BR; Katz ML; Coates JR; Kennedy D; Tiger P; Kanazono S; Lobel P; Sohar I; Xu S; Cahayag R; Keve S; Koren E; Bunting S; Tsuruda LS; O'Neill CA Mol Genet Metab; 2011 Nov; 104(3):325-37. PubMed ID: 21784683 [TBL] [Abstract][Full Text] [Related]
20. Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers. Sleat DE; Tannous A; Sohar I; Wiseman JA; Zheng H; Qian M; Zhao C; Xin W; Barone R; Sims KB; Moore DF; Lobel P J Proteome Res; 2017 Oct; 16(10):3787-3804. PubMed ID: 28792770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]